Authors:
Schrijver, IA
Melief, MJ
Markusse, HM
Van Aelst, I
Opdenakker, G
Hazenberg, MP
Laman, JD
Citation: Ia. Schrijver et al., Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjects, RHEUMATOLOG, 40(4), 2001, pp. 438-446
Authors:
Wetzel, K
Menten, P
Opdenakker, G
Van Damme, J
Grone, HJ
Giese, N
Vecchi, A
Sozzani, S
Cornelis, JJ
Rommelaere, J
Dinsart, C
Citation: K. Wetzel et al., Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts, J GENE MED, 3(4), 2001, pp. 326-337
Authors:
Bartholome, EJ
Van Aelst, I
Koyen, E
Kiss, R
Willems, F
Goldman, M
Opdenakker, G
Citation: Ej. Bartholome et al., Human monocyte-derived dendritic cells produce bioactive gelatinase B: Inhibition by IFN-ss, J INTERF CY, 21(7), 2001, pp. 495-501
Authors:
Pagenstecher, A
Wussler, EM
Opdenakker, G
Volk, B
Campbell, IL
Citation: A. Pagenstecher et al., Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors, J NE EXP NE, 60(6), 2001, pp. 598-612
Authors:
Proost, P
Schutyser, E
Menten, P
Struyf, S
Wuyts, A
Opdenakker, G
Detheux, M
Parmentier, M
Durinx, C
Lambeir, AM
Neyts, J
Liekens, S
Maudgal, PC
Billiau, A
Van Damme, J
Citation: P. Proost et al., Amino-terminal truncation of CXCR3 agonists impairs receptor signaling andlymphocyte chemotaxis, while preserving antiangiogenic properties, BLOOD, 98(13), 2001, pp. 3554-3561
Authors:
Struyf, S
Stoops, G
Van Coillie, E
Gouwy, M
Schutyser, E
Lenaerts, JP
Fiten, P
Van Aelst, I
Proost, P
Opdenakker, G
Van Damme, J
Citation: S. Struyf et al., Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants, BIOCHEM, 40(39), 2001, pp. 11715-11722
Authors:
Van Coillie, E
Van Aelst, I
Wuyts, A
Vercauteren, R
Devos, R
De Wolf-Peeters, C
Van Damme, J
Opdenakker, G
Citation: E. Van Coillie et al., Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle, AM J PATH, 159(4), 2001, pp. 1405-1414
Authors:
D'Haese, A
Wuyts, A
Dillen, C
Dubois, B
Billiau, A
Heremans, H
Van Damme, J
Arnold, B
Opdenakker, G
Citation: A. D'Haese et al., In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse, J INTERF CY, 20(7), 2000, pp. 667-674
Authors:
Nelissen, I
Fiten, P
Vandenbroeck, K
Hillert, J
Olsson, T
Marrosu, MG
Opdenakker, G
Citation: I. Nelissen et al., PECAM1, MPO and PRKAR1A at chromosome 17q21-q24 and susceptibility for multiple sclerosis in Sweden and Sardinia, J NEUROIMM, 108(1-2), 2000, pp. 153-159
Authors:
Nelissen, I
Vandenbroeck, K
Fiten, P
Hillert, J
Olsson, T
Marrosu, MG
Opdenakker, G
Citation: I. Nelissen et al., Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis, J NEUROIMM, 105(1), 2000, pp. 58-63
Authors:
Fibbe, WE
Pruijt, JFM
van Kooyk, Y
Figdor, CG
Opdenakker, G
Willemze, R
Citation: We. Fibbe et al., The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem-cell mobilization, SEM HEMATOL, 37(1), 2000, pp. 19-24
Authors:
Andrei, G
Snoeck, R
De Clercq, E
Esnouf, R
Fiten, P
Opdenakker, G
Citation: G. Andrei et al., Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene, J GEN VIROL, 81, 2000, pp. 639-648
Authors:
Kleifeld, O
Van den Steen, PE
Frenkel, A
Cheng, F
Jiang, HL
Opdenakker, G
Sagi, I
Citation: O. Kleifeld et al., Structural characterization of the catalytic active site in the latent andactive natural gelatinase B from human neutrophils, J BIOL CHEM, 275(44), 2000, pp. 34335-34343
Authors:
Van den Steen, PE
Proost, P
Wuyts, A
Van Damme, J
Opdenakker, G
Citation: Pe. Van Den Steen et al., Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminalprocessing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact, BLOOD, 96(8), 2000, pp. 2573-2581
Authors:
Van den Steen, PE
Proost, P
Wuyts, A
Van Damme, J
Opdenakker, G
Citation: Pe. Van Den Steen et al., Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminalprocessing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact, BLOOD, 96(8), 2000, pp. 2673-2681
Authors:
Mattu, TS
Royle, L
Langridge, J
Wormald, MR
Van den Steen, PE
Van Damme, J
Opdenakker, G
Harvey, DJ
Dwek, RA
Rudd, PM
Citation: Ts. Mattu et al., O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase- HPLC and online tandem mass spectrometry: Implications for the domain organization of the enzyme, BIOCHEM, 39(51), 2000, pp. 15695-15704